Last reviewed · How we verify
NCT05897112
Comparative Efficacy of 10% Potassium Hydroxide Solution Versus Cryotherapy in Molluscum Contagiosum
Phase 1 trial testing Group A received cryotherpay in Molluscum Contagiosum in 60 participants. Completed in 30 April 2023.
30 April 2023
Quick facts
| Lead sponsor | Combined Military Hospital Abbottabad |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 November 2022 |
| Primary completion | 30 April 2023 |
| Estimated completion | 30 April 2023 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Group A received cryotherpay — full drug profile →
- Group B received 10% Potassium Hydroxide Solution — full drug profile →
Conditions studied
- Molluscum Contagiosum — all drugs for Molluscum Contagiosum →
Sponsor
Combined Military Hospital Abbottabad
Who can join
Adults 4 to 12, any sex, with Molluscum Contagiosum. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A total of sixty patients presented to the outpatient dermatology department of Combined military hospital (CMH) Abbottabad with signs of molluscum contagiosum clinically diagnosed meeting inclusion criteria were enrolled. Sample size was calculated using WHO sample size calculator. They were divided into two groups i.e Group A and Group B using lottery method. Patients in Group A were subjected to cryotherapy (liquid nitrogen gas) whereas patients in Group B patients were subjected to 10% potassium hydroxide solution for 3 weeks and were followed up at 2nd, 4th, 8th and 12th week for observing the progress of therapy in both groups on each follow up visit and ascertaining the efficacy respectively.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05897112
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Combined Military Hospital Abbottabad trials
Trials by the same sponsor.
- NCT07331792 — Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Treatment of Pityriasis Versicolor · Phase 1, PHASE2 · not yet recruiting
- NCT05895071 — Comparison of Topical 5%Potassium Hydroxide vs Liquid Nitrogen in the Treatment of Plane Warts · Phase 1 · completed
- NCT05887219 — Comparison of Azelaic Acid 20 % Cream Versus Hydroquinone 4% Cream as an Adjuvant to Oral Tranexamic Acid in Melasma · Phase 1 · completed
- NCT05887232 — Comparison of Co2 Laser Versus Co2 Laser With PRP in Scars · Phase 1 · completed
- NCT05885269 — Comparative Efficacy of Tacrolimus and Clobetasol Propionate in Alopecia Areata · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05897112 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Combined Military Hospital Abbottabad
- Last refreshed: 9 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05897112.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing